These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15867075)

  • 41. Brief report: delusional disorder in a male adolescent with high-functioning PDDNOS.
    Kurita H
    J Autism Dev Disord; 1999 Oct; 29(5):419-23. PubMed ID: 10587888
    [No Abstract]   [Full Text] [Related]  

  • 42. The usefulness of the Revised Psychoeducational Profile for the assessment of preschool children with pervasive developmental disorders.
    Portoghese C; Buttiglione M; Pavone F; Lozito V; De Giacomo A; Martinelli D; Margari L
    Autism; 2009 Mar; 13(2):179-91. PubMed ID: 19261687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone-induced paroxysmal perceptual alteration in a child with autism.
    Bozkurt H; Ayaydın H; Adak İ; Zoroğlu SS
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):470-1. PubMed ID: 23234592
    [No Abstract]   [Full Text] [Related]  

  • 44. Autism spectrum disorders: update of evaluation and treatment.
    Mikhail AG; King BH
    Curr Psychiatry Rep; 2001 Oct; 3(5):361-5. PubMed ID: 11559471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder.
    Dinnissen M; Dietrich A; van den Hoofdakker BJ; Hoekstra PJ
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):111-24. PubMed ID: 25385293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
    Lindsay RL; Eugene Arnold L; Aman MG; Vitiello B; Posey DJ; McDougle CJ; Scahill L; Pachler M; McCracken JT; Tierney E; Bozzolo D
    J Intellect Dev Disabil; 2006 Dec; 31(4):204-9. PubMed ID: 17178532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism.
    Troost PW; Lahuis BE; Hermans MH; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Clin Psychopharmacol; 2007 Feb; 27(1):52-7. PubMed ID: 17224713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The use of psychopharmaceutical agents in children].
    Minderaa RB; Intveld AN; Vink HJ
    Ned Tijdschr Geneeskd; 1989 Feb; 133(5):252-6. PubMed ID: 2927536
    [No Abstract]   [Full Text] [Related]  

  • 49. Diagnosis and evaluation of pervasive developmental disorders.
    Scahill L
    J Clin Psychiatry; 2005; 66 Suppl 10():19-25. PubMed ID: 16401146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risperidone for the core symptom domains of autism.
    Adetunji B; Mathews M; Osinowo T; Williams A
    Am J Psychiatry; 2006 Mar; 163(3):551; author reply 551-2. PubMed ID: 16513891
    [No Abstract]   [Full Text] [Related]  

  • 51. Desperately seeking solutions.
    Clancy F
    Minn Med; 2006 Mar; 89(3):30-5, 51. PubMed ID: 16669430
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosis of severe developmental disorders in children under three years of age.
    Markiewicz K; Pachalska M
    Med Sci Monit; 2007 Feb; 13(2):CR89-99. PubMed ID: 17261988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjunctive quetiapine may help depression comorbid with pervasive developmental disorders.
    Tufan AE; Kutlu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1570-1. PubMed ID: 19758575
    [No Abstract]   [Full Text] [Related]  

  • 54. How do I decide whether or not to use medication for my child with autism? Should I try behavior therapy first?
    Scahill L
    J Autism Dev Disord; 2008 Jul; 38(6):1197-8. PubMed ID: 18463973
    [No Abstract]   [Full Text] [Related]  

  • 55. Secretin treatment for autism.
    Rimland B
    N Engl J Med; 2000 Apr; 342(16):1216-7; author reply 1218. PubMed ID: 10777377
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacotherapy of children and adolescents with pervasive developmental disorders.
    Hanft A; Hendren RL
    Essent Psychopharmacol; 2004; 6(1):12-24. PubMed ID: 15612651
    [No Abstract]   [Full Text] [Related]  

  • 57. Risperidone in children with autism and serious behavioral problems.
    Valiquette G
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071
    [No Abstract]   [Full Text] [Related]  

  • 58. Developing drugs for core social and communication impairment in autism.
    Posey DJ; Erickson CA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):787-801, viii-ix. PubMed ID: 18775370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiological findings of pervasive developmental disorders in a Venezuelan study.
    Montiel-Nava C; Peña JA
    Autism; 2008 Mar; 12(2):191-202. PubMed ID: 18308767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lessons from secretin.
    Volkmar FR
    N Engl J Med; 1999 Dec; 341(24):1842-4. PubMed ID: 10588973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.